MIR4472-1

Across TCGA pan-cancer cohorts, MIR4472-1 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR4472-1 data layer.

The strongest signal is observed in thymoma (THYM), where higher MIR4472-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4472-1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

THYM, MESO, and PAAD are the cancer types where MIR4472-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.169	0.879	<.001	108	view →
MESO	DFS	Tertile	III,IV	0.128	0.389	.001	54	view →
PAAD	OS	Tertile	All	0.258	0.604	<.001	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
OV	OS	Tertile	IV	0.181	0.780	<.001	36	view →
LIHC	DFS	Tertile	II,III,IV	0.067	0.429	<.001	36	view →
THCA	DFS	Tertile	II,III,IV	0.441	0.874	<.001	33	view →
BLCA	OS	Tertile	II,III,IV	1.000	0.427	.030	30	view →
KIRC	DFS	Tertile	All	0.499	0.805	.002	18	view →
KIRP	DFS	Tertile	All	0.218	0.771	.029	18	view →
SKCM	DFS	Tertile	All	1.000	0.613	.017	18	view →
COAD	OS	Tertile	III,IV	0.163	0.791	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR4472-1–THYM (OS)

Open the THYM breakdown →